Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways

Figure 3

Effects of AZIL and AD-MSCs on hepatic function biomarkers; liver index (a), serum ALT (b), serum AST (c) activities, and serum albumin (d) of CISP-injected rats. Data are represented as mean ± SEM (n = 6). Followed by Tukey–Kramer multiple comparisons test, analyses were carried out utilizing one-way ANOVA, where: , in comparison with CONT group. ^## and ^###, in comparison with the CISP group. ^{^^} and ^{^^^}, in comparison with CISP + AZIL.L group. ⁺⁺ and ⁺⁺⁺, in comparison with CISP + AZIL.H group. ^$, ^$$, and ^$$$, in comparison with CISP + AD-MSCs group.

(a)

(b)

(c)

(d)